DRTS Form 144: 17,500 shares reported sold

Alpha Tau Medical Ltd. Form 144 notice reports resale activity and prior RSU issuances.

Rhea-AI Filing Summary

Alpha Tau Medical Ltd. Form 144 notice reports resale activity and prior RSU issuances. The filing lists a broker-dealer, Oppenheimer & Co. Inc., with 20,000 shares and $201,000 dated 06/25/2026. It also shows that Raphi Levy sold 17,500 ordinary shares on 06/23/2026 for $167,051. The record includes earlier shares issued upon vesting of RSUs: 21,722 shares on 07/06/2022 and 65,750 shares on 04/01/2023.

Insights

Corporate Governance Analyst

Form 144 discloses a Rule 144 resale and prior RSU issuances without further qualifiers.

The filing lists a broker-dealer (Oppenheimer & Co. Inc.) and identifies $201,000 associated with 20,000 shares dated 06/25/2026. It separately documents a reported sale of 17,500 ordinary shares on 06/23/2026 for $167,051. These entries align with routine resale notice formatting.

Timing and cash-flow counterparties beyond the broker details are not expanded in the excerpt; subsequent filings or trade confirmations would show settlement mechanics and whether the sale was by a control or affiliate holder.

Key Figures

Broker-listed shares: 20,000 shares Broker-listed aggregate amount: $201,000 Reported sold shares: 17,500 shares +3 more

6 metrics

Broker-listed shares 20,000 shares listed with Oppenheimer & Co.; <date>06/25/2026</date>

Broker-listed aggregate amount <money>$201,000</money> associated with 20,000 shares; <date>06/25/2026</date>

Reported sold shares 17,500 shares sale by Raphi Levy on <date>06/23/2026</date>

Proceeds from reported sale <money>$167,051</money> proceeds tied to 17,500-share sale on <date>06/23/2026</date>

RSUs vested (2022) 21,722 shares issued upon vesting of RSUs on <date>07/06/2022</date>

RSUs vested (2023) 65,750 shares issued upon vesting of RSUs on <date>04/01/2023</date>

Key Terms

Rule 144, RSUs, broker-dealer

3 terms

Rule 144 regulatory

"Securities Sold During The Past 3 Months"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

RSUs financial

"Shares issued upon vesting of RSUs"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

broker-dealer market

"Oppenheimer & Co. Inc. 85 Broad St. New York"

A broker-dealer is a licensed firm or individual that both executes trades on behalf of clients (acting as a broker) and buys or sells securities for its own account (acting as a dealer). Investors care because broker-dealers provide the plumbing of markets — they place orders, hold or move cash and securities, offer research or advice, and their stability and fees directly affect trade execution, costs, and the safety of client funds; think of them as a combined travel agent and taxi for your investments.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the DRTS Form 144 disclose about recent sales?

It discloses a reported resale of 17,500 ordinary shares on 06/23/2026 for $167,051. The entry appears in the "Securities Sold During The Past 3 Months" section as a reported sale by Raphi Levy.

Does the filing show any broker or placement details for the resale?

Yes. The filing lists Oppenheimer & Co. Inc. with 20,000 shares and $201,000 tied to 06/25/2026. The excerpt provides broker identification and associated numeric entries.

Were any shares recently issued to insiders via RSUs according to this filing?

Yes. The filing records RSU vesting issuances of 21,722 ordinary shares on 07/06/2022 and 65,750 ordinary shares on 04/01/2023. Each line states "No consideration, shares issued upon vesting of RSUs."

Does the Form 144 indicate who received the sale proceeds?

The excerpt reports the sale proceeds amount $167,051 for the 17,500 shares sold on 06/23/2026. It does not specify the final recipient or use of proceeds within the provided text.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/26/2026 - 06:45 AM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001968095
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Alpha Tau Medical Ltd.
SEC File Number	001-41316
Address of Issuer	KIRYAT HAMADA 5 JERUSALEM ISRAEL 9777605
Phone	972-3-577-4115
Name of Person for Whose Account the Securities are To Be Sold	Levy Raphi
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary Shares	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	20000	201000.00	88009737	06/25/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary Shares	07/06/2022	Shares issued upon vesting of RSUs	Alpha Tau Medical Ltd.			21722	07/06/2022	No consideration, shares issued upon vesting of RSUs
Ordinary Shares	04/01/2023	Shares issued upon vesting of RSUs	Alpha Tau Medical Ltd.			65750	04/01/2023	No consideration, shares issued upon vesting of RSUs

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Raphi Levy KIRYAT HAMADA 5 Jerusalem L3 9777605	Ordinary Shares	06/23/2026	17500	167051.00

144: Remarks and Signature

Remarks	The securities are being sold pursuant to a Rule 10b51 trading plan adopted on March 24, 2026.
Date of Notice	06/25/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/24/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Raphael Levy By: /s/ Yohanan Azriel Title: Authorized Signatory, Oppenheimer Israel (pursuant to delegation)
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)